Randomized double-blind placebo-controlled trial of topical aloe vera gel for prevention of radiation-induced dermatitis in head and neck cancer patients received concurrent chemoradiation.
Phase 3
Completed
- Conditions
- head and neck cancerradiation dermatitisconcurrent chemoradiationhead and neck canceraloe vera gelradiation dermatitis
- Registration Number
- TCTR20200727002
- Lead Sponsor
- udon thani cancer hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1.age > 18 years old
2.Histopathologic confirmed head and neck cancer
3.treated with concurrent chemoradiation with at least dosage of 50 Gy at neck
4.ECOG 0-2
Exclusion Criteria
1. History of autoimmune disease
2. history of aloe vera allergy
3. denial for recruit in the trial
4. loss follow up patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RISRAS score (objectives) weekly investigation
- Secondary Outcome Measures
Name Time Method RISRAS score (subjecives) weekly quentionaires